Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

8.64
Delayed Data
As of Jan 20
 -0.11 / -1.26%
Today’s Change
7.12
Today|||52-Week Range
12.15
-7.10%
Year-to-Date
Better Buy: Opko Health, Inc. vs. Qiagen
Jan 18 / MotleyFool.com - Paid Partner Content
How a Bust Caused Opko Health Shares to Tumble in 2016
Jan 10 / MotleyFool.com - Paid Partner Content
It's Full Speed Ahead for Opko Health After Pipeline Stumble
Jan 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close8.75
Today’s open8.76
Day’s range8.62 - 8.81
Volume2,914,551
Average volume (3 months)4,312,354
Market cap$4.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratioNM
Price/Sales9.97
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-2.04-4.24%
VRXValeant Pharmaceutic...-0.17-1.14%
GRFSGrifols SA+0.04+0.24%
TAROTaro Pharmaceutical ...-1.34-1.32%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts


Search for Jobs